FR2752737B1 - CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE - Google Patents

CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE

Info

Publication number
FR2752737B1
FR2752737B1 FR9610551A FR9610551A FR2752737B1 FR 2752737 B1 FR2752737 B1 FR 2752737B1 FR 9610551 A FR9610551 A FR 9610551A FR 9610551 A FR9610551 A FR 9610551A FR 2752737 B1 FR2752737 B1 FR 2752737B1
Authority
FR
France
Prior art keywords
controlled release
release tablet
alfuzosine
hydrochloride
alfuzosine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9610551A
Other languages
French (fr)
Other versions
FR2752737A1 (en
Inventor
Lauretta Maggi
Ubaldo Conte
Pascal Grenier
Guy Vergnault
Alain Dufour
Francois Xavier Jarreau
Clemence Rauch-Desanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9610551A priority Critical patent/FR2752737B1/en
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to CA002264250A priority patent/CA2264250C/en
Priority to SK270-99A priority patent/SK284388B6/en
Priority to MXPA99001958A priority patent/MXPA99001958A/en
Priority to BRPI9713237-3A priority patent/BR9713237B1/en
Priority to AT97937651T priority patent/ATE200864T1/en
Priority to DK97937651T priority patent/DK0938318T3/en
Priority to PL331862A priority patent/PL191546B1/en
Priority to JP51133198A priority patent/JP3797388B2/en
Priority to DE69704712T priority patent/DE69704712T2/en
Priority to PCT/FR1997/001515 priority patent/WO1998008515A1/en
Priority to EP97937651A priority patent/EP0938318B1/en
Priority to CNB971975582A priority patent/CN1155382C/en
Priority to APAP/P/1999/001470A priority patent/AP1107A/en
Priority to ES97937651T priority patent/ES2159400T3/en
Priority to SI9730158T priority patent/SI0938318T1/en
Priority to AU40201/97A priority patent/AU724490B2/en
Priority to PT97937651T priority patent/PT938318E/en
Priority to IL12814697A priority patent/IL128146A/en
Priority to CZ1999655A priority patent/CZ295066B6/en
Priority to HU9903428A priority patent/HU228007B1/en
Priority to RU99105730/14A priority patent/RU2183459C2/en
Priority to US09/147,581 priority patent/US6149940A/en
Priority to NZ334018A priority patent/NZ334018A/en
Priority to CNB2004100422955A priority patent/CN100335057C/en
Priority to KR1019997001666A priority patent/KR100364328B1/en
Priority to UA99020755A priority patent/UA69374C2/en
Priority to EEP199900090A priority patent/EE03855B1/en
Priority to TR1999/00289T priority patent/TR199900289T2/en
Priority to ARP970103839A priority patent/AR009312A1/en
Priority to TW086112274A priority patent/TW522023B/en
Priority to ZA9707766A priority patent/ZA977766B/en
Priority to CO97049830A priority patent/CO4920217A1/en
Publication of FR2752737A1 publication Critical patent/FR2752737A1/en
Application granted granted Critical
Publication of FR2752737B1 publication Critical patent/FR2752737B1/en
Priority to IS4964A priority patent/IS2091B/en
Priority to BG103138A priority patent/BG63768B1/en
Priority to OA9900042A priority patent/OA10983A/en
Priority to NO19990944A priority patent/NO326206B1/en
Priority to HK99105968A priority patent/HK1020875A1/en
Priority to GR20010401141T priority patent/GR3036291T3/en
Priority to CY0200038A priority patent/CY2284B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
FR9610551A 1996-08-29 1996-08-29 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE Expired - Lifetime FR2752737B1 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (en) 1996-08-29 1996-08-29 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE
US09/147,581 US6149940A (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorhydrate
MXPA99001958A MXPA99001958A (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate.
SK270-99A SK284388B6 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorhydrate
AT97937651T ATE200864T1 (en) 1996-08-29 1997-08-22 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE
DK97937651T DK0938318T3 (en) 1996-08-29 1997-08-22 Controlled-release tablet of alfuzosin chlorohydrate
PL331862A PL191546B1 (en) 1996-08-29 1997-08-22 Tablet featurated by controllable release of alphusozine hydrochloride contained therein
JP51133198A JP3797388B2 (en) 1996-08-29 1997-08-22 Controlled release tablets of alfuzosin hydrochloride
DE69704712T DE69704712T2 (en) 1996-08-29 1997-08-22 TABLET WITH CONTROLLED RELEASE OF ALFUZOSINE HYDROCHLORIDE
PCT/FR1997/001515 WO1998008515A1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
RU99105730/14A RU2183459C2 (en) 1996-08-29 1997-08-22 Tablet with controlled alfuzosin hydrochloride release
CNB971975582A CN1155382C (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
NZ334018A NZ334018A (en) 1996-08-29 1997-08-22 Multilayered controlled release tablet comprising a layer of alfuzosin hydrochloride and at least one layer of hydrophillic polymers
ES97937651T ES2159400T3 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosin hydrochloride
SI9730158T SI0938318T1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
AU40201/97A AU724490B2 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosin hydrochloride
PT97937651T PT938318E (en) 1996-08-29 1997-08-22 TABLET WITH CONTROLLED FREEDOM OF ALFUZOSINE CHLORIDRATE
IL12814697A IL128146A (en) 1996-08-29 1997-08-22 Three layered tablet with controlled release of alfuzosin hydrochloride
CZ1999655A CZ295066B6 (en) 1996-08-29 1997-08-22 Controlled release tablet of alfuzosin hydrochloride and pharmaceutical composition in which it is comprised
HU9903428A HU228007B1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
CA002264250A CA2264250C (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosin hydrochloride
BRPI9713237-3A BR9713237B1 (en) 1996-08-29 1997-08-22 Alfuzosine hydrochloride controlled release tablet and pharmaceutical composition comprising the same.
APAP/P/1999/001470A AP1107A (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate.
CNB2004100422955A CN100335057C (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorhydrate
KR1019997001666A KR100364328B1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
UA99020755A UA69374C2 (en) 1996-08-29 1997-08-22 Tableted dosage form for delayed release of alfusosin hydrochloride
EEP199900090A EE03855B1 (en) 1996-08-29 1997-08-22 Alfuzosin hydrochloride controlled release tablet
TR1999/00289T TR199900289T2 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosin hydrochloride.
EP97937651A EP0938318B1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
ARP970103839A AR009312A1 (en) 1996-08-29 1997-08-25 PHARMACEUTICAL TABLET INTENDED FOR THE ORAL WAY, FOR THE CONTROLLED RELEASE OF ALFUZOSINE CHLORHYDRATE AT THE LEVEL OF THE PROXIMAL SEGMENTS OF THE GASTROINTESTINAL TRACT AND PHARMACEUTICAL COMPOSITION, INCLUDING ONE OR MULTIPLE TABLETS.
TW086112274A TW522023B (en) 1996-08-29 1997-08-26 Tablet with controlled release of alfuzosin hydrochloride
ZA9707766A ZA977766B (en) 1996-08-29 1997-08-28 Tablet with controlled release of alfuzosin hydrochloride.
CO97049830A CO4920217A1 (en) 1996-08-29 1997-08-28 ALFUZOSINE CHLORHYDRATE CONTROLLED RELEASE TABLET
IS4964A IS2091B (en) 1996-08-29 1999-01-29 Solvent control tablet for alfusosin chlorohydrate
BG103138A BG63768B1 (en) 1996-08-29 1999-02-01 Tablets with controlled alphuzozine hydrochloride release
NO19990944A NO326206B1 (en) 1996-08-29 1999-02-26 Pharmaceutical tablet with controlled release of alfuzosin hydrochloride
OA9900042A OA10983A (en) 1996-08-29 1999-02-26 Controlled release tablet of alfuzosin hydrochloride.
HK99105968A HK1020875A1 (en) 1996-08-29 1999-12-20 Tablet with controlled release of alfuzosine chlorydrate
GR20010401141T GR3036291T3 (en) 1996-08-29 2001-07-26 Tablet with controlled release of alfuzosine chlorydrate
CY0200038A CY2284B1 (en) 1996-08-29 2002-05-15 Tablet with controlled release of alfuzosine chlorydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (en) 1996-08-29 1996-08-29 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE

Publications (2)

Publication Number Publication Date
FR2752737A1 FR2752737A1 (en) 1998-03-06
FR2752737B1 true FR2752737B1 (en) 1998-10-02

Family

ID=9495273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9610551A Expired - Lifetime FR2752737B1 (en) 1996-08-29 1996-08-29 CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE

Country Status (2)

Country Link
FR (1) FR2752737B1 (en)
ZA (1) ZA977766B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
ITMI20050391A1 (en) * 2005-03-11 2006-09-12 Ph & T S P A CONTROLLED RELEASE FORMULATIONS OF ALFUZOSIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2582513B1 (en) * 1985-05-28 1988-08-05 Synthelabo PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
FR2717388B1 (en) * 1994-03-21 1996-11-22 Synthelabo Extended release dosage forms of alfuzosin hydrochloride.

Also Published As

Publication number Publication date
FR2752737A1 (en) 1998-03-06
ZA977766B (en) 1998-02-23

Similar Documents

Publication Publication Date Title
ATE200864T1 (en) CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE
NO980240D0 (en) Paroxetine controlled release mixtures
ZA975675B (en) Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one
IS1998B (en) 4 '' substituents - 9 - deoxo - 9 - aza - 9a - homoeriodomycin A derivatives
EP0828751A4 (en) Human neuropeptide receptor
DK0733367T3 (en) Oral olanzapine formulation
DK0880892T3 (en) Controlled release agents
EP0853629A4 (en) Hepadnavirus receptor
PL326604A1 (en) Derivatives of 5"-dezoxy-cytidin
DE69623861D1 (en) Knee full denture
EP0809648A4 (en) Neuropeptide y receptor
NO20001050D0 (en) Procedure for making a cast article
FR2752737B1 (en) CONTROLLED RELEASE TABLET OF ALFUZOSINE HYDROCHLORIDE
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
GB9505191D0 (en) Therapeutic benzoxazoles
DZ2386A1 (en) Microparticulate form of a tetrahydropyridine derivative
IL117465A0 (en) A pharmaceutical use of certain cystine derivatives
FR2742197B1 (en) RELEASE COUPLING
IL151450A0 (en) Extended release formulation of venlafazine hydrochloride
GB9515060D0 (en) Therapeutic heterocyclic compounds
FI950008A (en) Pharmaceutical composition for controlled release
IL117969A0 (en) Inhibiting photodecomposition of 3-substituted-2-oxinoles
HUP0001457A3 (en) Novel therapeutic application of a thienycyclohexylamine derivative
ZA953792B (en) Human neuropeptide receptor
TW332432U (en) Improved medicated plaster

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 20